Bone Morphogenetic Protein-Smad Pathway as Drug Targets for Osteoporosis and Cancer Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
8
Page:
208-219
Author(s):
Baojie Li
Targeted Therapies in Head and Neck Cancer: Past, Present and Future
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
156-166
Author(s):
Alexander D. Rapidis, Jan B. Vermorken and Jean Bourhis
Chromatin Remodeling Agents for Cancer Therapy
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
192-203
Author(s):
La Sala Dario, Magnano Anna Rosa, Estenoz Mariela, Giordano Roberto and Cinti Caterina
Chemotherapy in Addition to Preoperative Radiotherapy in Locally Advanced Rectal Cancer – A Systematic Overview
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
204-211
Author(s):
Bengt Glimelius, Torbjorn Holm and Lennart Blomqvist
The Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
217-227
Author(s):
Antonio Rossi, Emilio Bria, Paolo Maione, Giovanni Palazzolo, Marzia Falanga and Cesare Gridelli
Cytokines in Colitis-Associated Cancer: Potential Drug Targets?
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
7
Page:
187-194
Author(s):
Maximilian J. Waldner, Markus F. Neurath and Markus
Current Dendrimer Applications in Cancer Diagnosis and Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
8
Page:
1165-1179
Author(s):
Istvan J. Majoros, Christopher R. Williams and James R. Baker Jr.
Astatine Radiopharmaceuticals: Prospects and Problems
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
177-196
Author(s):
Ganesan Vaidyanathan and Michael R. Zalutsky
Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
392-403
Author(s):
Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome
Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
414-420
Author(s):
A. Gradilone, F. M. Pulcinelli, L. V. Lotti, E. Trifiro, S. Martino, O. Gandini, W. Gianni, L. Frati, A. M. Agliano and P. Gazzaniga